DE60031262D1 - Menschliche promotoren des gaba b-rezeptors 1 - Google Patents

Menschliche promotoren des gaba b-rezeptors 1

Info

Publication number
DE60031262D1
DE60031262D1 DE60031262T DE60031262T DE60031262D1 DE 60031262 D1 DE60031262 D1 DE 60031262D1 DE 60031262 T DE60031262 T DE 60031262T DE 60031262 T DE60031262 T DE 60031262T DE 60031262 D1 DE60031262 D1 DE 60031262D1
Authority
DE
Germany
Prior art keywords
gaba
receptor
sub
promoters
human promoters
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60031262T
Other languages
English (en)
Other versions
DE60031262T2 (de
Inventor
Jonas Ekstrand
Anders Edlund
Thore Johansson
Goeran Leonardsson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Application granted granted Critical
Publication of DE60031262D1 publication Critical patent/DE60031262D1/de
Publication of DE60031262T2 publication Critical patent/DE60031262T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
    • C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian

Landscapes

  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DE60031262T 1999-05-06 2000-05-04 Menschliche promotoren des gaba b-rezeptors 1 Expired - Fee Related DE60031262T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9901659A SE9901659D0 (sv) 1999-05-06 1999-05-06 New methods
SE9901659 1999-05-06
PCT/SE2000/000878 WO2000068268A1 (en) 1999-05-06 2000-05-04 Human gabab receptor 1 promoters

Publications (2)

Publication Number Publication Date
DE60031262D1 true DE60031262D1 (de) 2006-11-23
DE60031262T2 DE60031262T2 (de) 2007-05-10

Family

ID=20415508

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60031262T Expired - Fee Related DE60031262T2 (de) 1999-05-06 2000-05-04 Menschliche promotoren des gaba b-rezeptors 1

Country Status (10)

Country Link
US (2) US6933124B1 (de)
EP (1) EP1179021B1 (de)
JP (1) JP2003502020A (de)
AT (1) ATE342280T1 (de)
AU (1) AU4637200A (de)
CA (1) CA2372597A1 (de)
DE (1) DE60031262T2 (de)
ES (1) ES2273691T3 (de)
SE (1) SE9901659D0 (de)
WO (1) WO2000068268A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6857600A (en) * 1999-08-31 2001-03-26 Glaxo Group Limited Screen

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2254862A1 (en) 1996-05-30 1997-12-11 Novartis Ag Metabotropic gaba[b] receptors, receptor-specific ligands and their uses
CA2308102A1 (en) * 1997-10-27 1999-05-06 Astrazeneca Aktiebolag New nucleotide sequences

Also Published As

Publication number Publication date
US20060019345A1 (en) 2006-01-26
CA2372597A1 (en) 2000-11-16
WO2000068268A1 (en) 2000-11-16
JP2003502020A (ja) 2003-01-21
ATE342280T1 (de) 2006-11-15
DE60031262T2 (de) 2007-05-10
ES2273691T3 (es) 2007-05-16
AU4637200A (en) 2000-11-21
SE9901659D0 (sv) 1999-05-06
US6933124B1 (en) 2005-08-23
US7348163B2 (en) 2008-03-25
EP1179021B1 (de) 2006-10-11
EP1179021A1 (de) 2002-02-13

Similar Documents

Publication Publication Date Title
DE50113396D1 (de) System zur gezielten Deformation von optischen Elementen
DE60236367D1 (de) Echolöscher, der eine weitere reduktion des restechos sicherstellt
NO990025L (no) Hamster-EF-1<alfa> transkripsjonsregulatorisk DNA
EE200100441A (et) Monoamiinide taasomastamise inhibiitorid kesknärvisüsteemi haiguste raviks
WO2002036743A3 (en) Antisense modulation of calreticulin expression
AU4929701A (en) Whole-body optical imaging of gene expression and uses thereof
WO2001047944A3 (en) Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
WO2003052072A3 (en) Antisense modulation of estrogen receptor alpha expression
DK1123414T3 (da) Antisense-modulering af integrin alpha 4.ekspression
WO2000029623A3 (en) Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
NO20014241D0 (no) C16-umettede FP-selektive prostaglandinanaloger
WO2003104397A3 (en) ANTISENSE MODULATION OF PROTEIN KINASE GR 6 EXPRESSION
WO2003050244A3 (en) Antisense modulation of g protein-coupled receptor etbr-lp-2 expression
DE60031262D1 (de) Menschliche promotoren des gaba b-rezeptors 1
NO20041763L (no) Regulert nukleinsyreekspresjonssystem
DE69942200D1 (de) Parvovirus NS1 Varianten
EP1474434A4 (de) Der eaat2-promotor und dessen verwendung
WO2001040521A3 (en) Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
WO2001048245A3 (en) Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
ATE518963T1 (de) Evaneszenz-basierendes multiplex- sequenzierungsverfahren
DE60124791D1 (de) S-Methyl-Dihydro-Ziprasidone zur Behandlung von psychiatrischen Störungen.
ATE291435T1 (de) Chlorzoxazon zur behandlung von psoriasis
WO2001051670A3 (en) Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
WO2000029622A3 (en) Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
ITMI20001317A0 (it) Procedimento per la purificazione di diacereina.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee